ketamine. Anaesthetic, unspecified
Conditions
Interventions
Intervention 1: in the first group ketamine 0.5 mg/ml is added to fentanlyl 5 µg/ml via intravenous patient-controlled analgesia. Intervention 2: in the second group ketorolac 0.6 mg/ml is added to fe
Treatment - Drugs
in the first group ketamine 0.5 mg/ml is added to fentanlyl 5 µg/ml via intravenous patient-controlled analgesia
in the second group ketorolac 0.6 mg/ml is added to fentanlyl 5 µg/ml via intravenous patient-controlled analgesia
Sponsors
Shahid Sadoughi University of Medical Science
Eligibility
Sex/Gender
Female
Age
40 Years to 60 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: women with American Society of Anesthesia (ASA) physical status I or II who are candidate for elective abdominal hysterectomy, age 40-60 years old Exclusion criteria: patients with BMI>35 and a history of mental impairment,chronic pain,allergic reactions to the study drugs,addiction were excluded.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Postoperative pain. Timepoint: 2,6,12,24 hours postoperatively. Method of measurement: visual analog pain score. | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effects(respiratory depression,nausea,vomiting,Hallucination). Timepoint: 2, 6, 12 and 24 hours after operation. Method of measurement: asking the patient, physical examination. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Shekoufeh Behdad
Shahid Sadoughi University of Medical Sciences
Outcome results
None listed